Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion type Assertion NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_head.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion description "[In conclusion, our results point to COX-2 as a potential therapeutic target against obesity-associated metabolic dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion evidence source_evidence_literature NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion SIO_000772 25422106 NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion wasDerivedFrom befree-2016 NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.
- NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_assertion wasGeneratedBy ECO_0000203 NP1239739.RAD6MCC6-Nw4HCFKyEFxmEb6gqJNTBTptgOCEsvz-Q5W0130_provenance.